Sonova Holding AG

Sonova Holding is a hearing instrument manufacturer based in Switzerland. Co. specializes in the design, development, manufacture, and worldwide distribution of technologically advanced wireless and hearing systems for adults and children with hearing impairment. Co. offers a range of digital hearing instruments, along with high tech specialty products and complementary wireless communications systems. Co. comprises two hearing instrument divisions, Phonak and Unitron Hearing, as well as Phonak Communications, a developer of wireless communication devices for both hearing instrument and other applications.
  • TickerPHBN
  • ISINCH0012549785
  • ExchangeSix Swiss Exchange
  • SectorHealth Care Equipment & Services
  • CountrySwitzerland

Analysts

1 director sold

A director at Sonova Holding Ag sold 2,090 shares at 222.479CHF and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of bo...

SONOVA HOLDING AG reduced its risk exposure resulting in an upgrade to Slightly Positive

SONOVA HOLDING AG (CH), a company active in the Medical Equipment industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date June 14, 2019, the closing price was CHF 230.60 and its potential was estimated at CHF 242.13.

Alex Morozov

Morningstar | SOON Updated Forecasts and Estimates from 03 Jun 2019

Sonova's second-half results showed material sequential improvement, largely due to a successful launch of the Marvel platform. We're maintaining our fair value estimate and narrow moat rating. The shares appear slightly overvalued at current levels. Sonova's strong finish to the year in the wholesale business was largely expected as the firm's November launch of Audeo Marvel reaccelerated unit volume and meaningfully improved pricing. The hearing instruments business (wholesale) overall was up 8% in local currency in the second half (versus 0.5% in the first half), with Europe, the Middle Ea...

Alex Morozov

Morningstar | Sonova Finishes Fiscal Year Strong; Maintaining FVE

Sonova's second-half results showed material sequential improvement, largely due to a successful launch of the Marvel platform. We're maintaining our fair value estimate and narrow moat rating. The shares appear slightly overvalued at current levels. Sonova's strong finish to the year in the wholesale business was largely expected as the firm's November launch of Audeo Marvel reaccelerated unit volume and meaningfully improved pricing. The hearing instruments business (wholesale) overall was up 8% in local currency in the second half (versus 0.5% in the first half), with Europe, the Middle Ea...

Alex Morozov

Sonova Finishes Fiscal Year Strong; Maintaining FVE

Sonova's second-half results showed material sequential improvement, largely due to a successful launch of the Marvel platform. We're maintaining our fair value estimate and narrow moat rating. The shares appear slightly overvalued at current levels. Sonova's strong finish to the year in the wholesale business was largely expected as the firm's November launch of Audeo Marvel reaccelerated unit volume and meaningfully improved pricing. The hearing instruments business (wholesale) overall was up ...

Alex Morozov

Morningstar | SOON Updated Forecasts and Estimates from 03 Jun 2019

Sonova's second-half results showed material sequential improvement, largely due to a successful launch of the Marvel platform. We're maintaining our fair value estimate and narrow moat rating. The shares appear slightly overvalued at current levels. Sonova's strong finish to the year in the wholesale business was largely expected as the firm's November launch of Audeo Marvel reaccelerated unit volume and meaningfully improved pricing. The hearing instruments business (wholesale) overall was up 8% in local currency in the second half (versus 0.5% in the first half), with Europe, the Middle Ea...

Alex Morozov

Morningstar | Sonova Finishes Fiscal Year Strong; Maintaining FVE

Sonova's second-half results showed material sequential improvement, largely due to a successful launch of the Marvel platform. We're maintaining our fair value estimate and narrow moat rating. The shares appear slightly overvalued at current levels. Sonova's strong finish to the year in the wholesale business was largely expected as the firm's November launch of Audeo Marvel reaccelerated unit volume and meaningfully improved pricing. The hearing instruments business (wholesale) overall was up 8% in local currency in the second half (versus 0.5% in the first half), with Europe, the Middle Ea...

Alex Morozov

Sonova Finishes Fiscal Year Strong; Maintaining FVE

Sonova's second-half results showed material sequential improvement, largely due to a successful launch of the Marvel platform. We're maintaining our fair value estimate and narrow moat rating. The shares appear slightly overvalued at current levels. Sonova's strong finish to the year in the wholesale business was largely expected as the firm's November launch of Audeo Marvel reaccelerated unit volume and meaningfully improved pricing. The hearing instruments business (wholesale) overall was up ...

Alex Morozov

Morningstar | Sonova's Product Refresh Needed to Reverse Struggles in U.S. Market

Sonova benefits from favorable trends, including an aging population, increasing noise pollution, fairly low penetration rates for hearing aids in the developed world, and virtually untapped patient populations in emerging markets. Its broad product offerings should allow the company to capitalize on these trends, while its strong brand and superior technological know-how should yield market share gains.Sonova controls more than one fifth of the world's hearing aid market by value, possessing roughly the same share as key competitor Demant. The two rivals are very similar in their approach to ...

Alex Morozov

Sonova's Product Refresh Needed to Reverse Struggles in U.S. Market

Sonova's first-half results were below our expectations, albeit much of the weakness was due to purchase deferrals ahead of the new product introduction launched this month. We are maintaining our fair value estimate for now, as the modest downward revision to our full-year forecast is largely offset by cash flows realized since our last report. There is, however, a greater uncertainty baked into our 2019 numbers, with volume and pricing highly contingent on the success of Phonak Marvel. We main...

1 director sold

A director at Sonova Holding Ag sold 2,090 shares at 222.479CHF and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of bo...

SONOVA HOLDING AG reduced its risk exposure resulting in an upgrade to Slightly Positive

SONOVA HOLDING AG (CH), a company active in the Medical Equipment industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date June 14, 2019, the closing price was CHF 230.60 and its potential was estimated at CHF 242.13.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Sonova – Proxinvest Corporate Governance Rating ® : B

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Health Care outperforming globally -- overweight; India breaking out -- add exposure With the primary global ex-U.S. indexes MSCI EAFE, MSCI EM, and MSCI ACWI ex-U.S. continuing their sideways to downward consolidation from a price perspective, the importance of Sector, Group, and stock selection is critical. • Sector and Group Opportunities. Today we put the spotlight on the Health Care Sector, which is assuming a global leadership role as it separates itself from the other international Sectors. We also focus on the Communications Sector as it has seen steady relative strength ranking (RSR...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch